{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "62485-051",
      "generic_name": "Guaifenesin and Dextromethorphan HBr",
      "labeler_name": "TCB USA Corporation",
      "active_ingredients": [
        {
          "name": "GUAIFENESIN",
          "strength": "400 mg/1"
        },
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "20 mg/1"
        }
      ],
      "finished": false,
      "packaging": [
        {
          "package_ndc": "62485-051-20",
          "description": "20000 TABLET in 1 BOX (62485-051-20)",
          "marketing_start_date": "09-JUL-18"
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {},
      "marketing_category": "DRUG FOR FURTHER PROCESSING",
      "dosage_form": "TABLET",
      "spl_id": "d6e00b4d-29ee-4116-98c2-71cf4193679c",
      "product_type": "DRUG FOR FURTHER PROCESSING",
      "marketing_start_date": "20180709",
      "product_id": "62485-051_d6e00b4d-29ee-4116-98c2-71cf4193679c",
      "brand_name_base": null
    }
  ]
}